You are here

Novo Nordisk

Novo Nordisk's blockbuster diabetes drug blows the doors off in obesity, proving highly effective in driving weight loss

Endpoints

Thu, 02/11/21 - 10:43 am

Novo Nordisk plots $1.3B in spending as it expands API production—and advances new oral meds

Fierce Pharma

Thu, 02/4/21 - 10:43 am

drug manufacturing

Novo Nordisk files for regulatory approval in the US of once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes

Yahoo/Global Newswire

Wed, 01/20/21 - 10:39 am

type 2 diabetes

Pharma TV ad spenders blow up December with spendiest month of 2020

Fierce Pharma

Wed, 01/6/21 - 10:50 am

Novo Nordisk’s gene silencing alliance with Dicerna bears first fruit

Pharmaforum

Wed, 01/6/21 - 10:42 am

Novo takes the plunge in Alzheimer’s

EP Vantage

Thu, 12/17/20 - 06:20 pm

Alzheimer's disease

Novo invests in Hemab, a company going against the hemophilia gene therapy grain with a plan for bispecifics

Endpoints

Mon, 12/14/20 - 10:53 am

Novo Nordisk to end 340B discounts on drugs dispensed at community pharmacies

Beckers Hospital Review

Tue, 12/8/20 - 11:10 pm

Gilead and Novo plot next steps after trial data from NASH combo

Pharmaforum

Mon, 11/16/20 - 10:19 am

Gilead Sciences

clinical trials

Novo Nordisk to boost pill-form diabetic drugs with $1.8 billion deal

Reuters

Fri, 11/6/20 - 10:40 am

pill technology

AASLD 2020 – Nash updates from Novo and Inventiva in focus

EP Vantage

Wed, 11/4/20 - 10:09 am

Gilead Sciences

Novo Nordisk quietly nabs a rare 'breakthrough' status in NASH for its cash cow

Endpoints

Fri, 10/30/20 - 10:25 am

breakthrough therapy

Novo Nordisk scraps Type 1 diabetes drug after phase 2 trial

Fierce Biotech

Fri, 10/30/20 - 10:16 am

clinical trials

type 1 diabetes

Heart to heart: Novo Nordisk teams with ACC to open diabetes discussion

Fierce Pharma

Mon, 09/28/20 - 10:39 am

pharma marketing

American College of Cardiology

cardiovascular disease

Novo adds weight to its obesity goals

EP Vantage

Thu, 09/10/20 - 10:17 am

Novo launches type 2 diabetes pill in UK after NICE waives review

Pharmaforum

Tue, 09/1/20 - 10:44 am

type 2 diabetes

How did Novo Nordisk's Sophia chatbot become a pharma industry standard? Empathy, timing and relevance: experts

Fierce Pharma

Tue, 08/18/20 - 11:08 pm

Novo Nordisk taps Evotec to target chronic kidney disease

Fierce Biotech

Tue, 08/18/20 - 11:14 am

chronic kidney disease

Novo gets PhIII hemophilia trials for a Roche rival back on track after completing work-around on blood clot threat

Endpoints

Thu, 08/13/20 - 09:48 am

clinical trials

Novo backs 'breakthrough' antifungal player's $60M round — with a focus on rare mold infections

Endpoints

Wed, 08/12/20 - 10:34 am

drug development

Pages